Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy

Child and Adolescent Psychiatry and Mental Health

Volumn 2, Issue , 2008, Pages

  Kratochvil, Christopher J ^a   Milton, Denái R ^b   Vaughan, Brigette S ^a   Greenhill, Laurence L ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; PLACEBO; PSYCHOSTIMULANT AGENT;

ABDOMINAL PAIN; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD PSYCHIATRY; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUGHING; DECREASED APPETITE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; HUMAN; IRRITABILITY; META ANALYSIS; MORNING DOSAGE; NAUSEA; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINOPHARYNGITIS; SIDE EFFECT; SOMNOLENCE; SORE THROAT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; VOMITING; WEIGHT REDUCTION;

EID: 53249129118     PISSN: None     EISSN: 17532000     Source Type: Journal    
DOI: 10.1186/1753-2000-2-25     Document Type: Article

References (25)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR, text revision Washington, DC: American Psychiatric Association 4 2000
2. Lavigne JV Gibbons RD Christoffel KK Arend R Rosenbaum D Binns H Dawson N Sobel H Isaacs C Prevalence rates and correlates of psychiatric disorders among preschool children J Am Acad Child Psychiatry 1996, 35:204-214 10.1097/00004583-199602000-00014 8720630
3. DuPaul GJ McGoey KE Eckert TL VanBrakle J Preschool children with attention-deficit/hyperactivity disorder: Impairments in behavioral, social, and school functioning J Am Acad Child Adolesc Psychiatry 2001, 40:508-515 10.1097/00004583-200105000-00009 11349694
4. Lahey BB Pelham WE Stein MA Loney J Trapani C Nugent K Kipp H Schmith E Lee S Cale M Gold E Hartung CM Willcutt E Baumann B Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children J Am Acad Child Adolesc Psychiatry 1998, 37:695-702 9666624
5. Mariani MA Barkley RA Neuropsychological and academic functioning in preschool boys with attention deficit hyperactivity disorder Dev Neuropsychol 1997, 13:111-129
6. Shelton TL Barkley RA Crosswait C Moorehouse M Fletcher K Barrett S Jenkins L Metevia L Psychiatric and psychological morbidity as a function of adaptive disability in preschool children with aggressive and hyperactive-impulsive-inattentive behavior J Abnorm Child Psychol 1998, 26:475-494 10.1023/A:1022603902905 9915654
7. MTA Cooperative Group A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder Arch Gen Psychiatry 1999, 56:1073-1086 10.1001/archpsyc.56.12.1073 10591283
8. Greenhill L Kollins S Abikoff H McCracken J Riddle M Swanson J McGough J Wigal S Wigal T Vitiello B Skrobala A Posner K Ghuman J Cunnigham C Davies M Chuang S Cooper T Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers With ADHD J Am Acad Child Adolesc Psychiatry 2006, 45:1284-1293 10.1097/01.chi.0000235077.32661.61 17023867
9. Pliszka S AACAP Work Group on Quality Issues Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 2007, 46:894-921 10.1097/chi.0b013e318054e724 17581453
10. Kratochvil CJ Vaughan BS Mayfield-Jorgensen ML March JS Kollins SH Murray DW Ravi H Greenhill LL Kotler LA Paykina N Biggins P Stoner J A pilot study of atomoxetine in young children with attention-deficit/ hyperactivity disorder J Child Adolesc Psychopharmacol 2007, 17:175-185 10.1089/cap.2006.0143 17489712
11. Allen AJ Michelson D Drug development process for a product with a primary pediatric indication J Clin Psychiatry 2002, 63(Suppl-12):44-49 12562061
12. Kelsey DK Sumner CR Casat CD Coury DL Quintana H Saylor KE Sutton VK Gonzales J Malcolm SK Schuh KJ Allen AJ Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial Pediatrics 2004, 114:e1-e8 10.1542/ peds.114.1.e1 15231966
13. Spencer TJ Heiligenstein JH Biederman J Faries DE Kratochvil CJ Conners CK Potter WZ Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder J Clin Psychiatry 2002, 63:1140-1147 12523874
14. Michelson D Allen AJ Busner J Casat C Dunn D Kratochvil C Newcorn J Sallee FR Sangal RB Saylor K West S Kelsey D Wernicke J Trapp NJ Harder D Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study Am J Psychiatry 2002, 159:1896-1901 10.1176/ appi.ajp.159.11.1896 12411225
15. Wilens TE Kratochvil CJ Newcorn J Thomason C Gao H Do Children and Adolescents with ADHD Respond Differently to Atomoxetine? J Am Acad Child Adolesc Psychiatry 2006, 45:149-157 10.1097/ 01.chi.0000190352.90946.0b 16429085
16. Kaufman J Birmaher B Brent D Rao U Ryan N Kiddie-SADS-Present and Lifetime Version (K-SADS-PL), version 1.0 of October 1996 edn Pittsburgh, PA: University of Pittsburgh Press 1996
17. Wechsler D Wechsler Intelligence Scale for Children (WISC-III) San Antonio, TX: The Psychological Corporation: Harcourt Brace and Company 3 1991
18. Newcorn J Kratochvil C Allen AJ Casat C Ruff D Moore R Michelson D Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response Am J Psychiatry 2008, 165:721-730 10.1176/ appi.ajp.2007.05091676 18281409
19. Kelsey D Sutton V Lewis DW Schuh K Sumner C Quintana H Morning-Versus Evening-Dosed Atomoxetine: Effects on Core ADHD Symptoms In Proceedings of the 158th Annual Meeting of the American Psychiatric Association: 21-26 May 2005; Atlanta
20. World Medical Association Declaration of Helsinki: Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects Cardiovasc Res 1997, 35(1):2-3 As adopted by the 18th General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd General Assembly, Edinburgh, Scotland, [October 2000] 10.1016/S0008-6363(97)00109-0 9302340
21. DuPaul GJ Power TJ Anastopoulos AD Reid R ADHD Rating Scale-IV: checklists, norms, and clinical interpretations New York: The Guilford Press 1998
22. Conners CK Conners' rating scales: Revised technical manual North Tonawanda: Multi-Health Systems Inc 1997
23. Guy W ECDEU assessment manual for psychopharmacology, revised. Publication ADM 76-338 Bethesda, MD: United States Department of Health, Education, and Welfare 1976
24. SAS Institute SAS/STAT software: Changes and enhancements through release 6.12 Cary, NC: SAS Institute 4 1997
25. Kratochvil CJ Wilens TE Greenhill LL Gao H Baker KD Feldman PD Gelowitz DL Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 2006, 45:919-927 10.1097/01.chi.0000222788.34229.68 16865034